Agilent Selects SeqWright as First Target Enrichment Certified Service Provider for AB SOLiD Sequencing

SureSelect, a research-use-only system, has been shown to greatly increase the speed and cost-efficiency of next-generation sequencing by enabling researchers to focus experiments on genomic regions of interest rather than sequencing the entire genome. The system offers optimized protocols for the Illumina Genome Analyzer and Life Technologies' AB SOLiD platforms.

When leading genomics companies like SeqWright add SureSelect to their extensive portfolios of services, it illustrates the momentum this technology has gained in just the year and a half since its introduction, said Fred P. Ernani, Ph.D., Agilent SureSelect platform business manager. We are very pleased to see SeqWright gain the status of the first CSP for SureSelect on the SOLiD platform.

All of us at SeqWright are very excited to have achieved CSP status for the SureSelect system, said Fei Lu, M.D., CEO of SeqWright. The coupling of SureSelect with our established SOLiD pipeline provides us with an unprecedented level of flexibility to address the many needs of our next-gen sequencing customers.